Cofactor Genomics

Adaptive Biotechnologies

This company provides immune-sequencing tests and research services for clinicians, biopharmaceutical firms and academic researchers to diagnose, monitor and treat diseases.

Biome Diagnostics

This company develops AI-powered microbiome diagnostic tools and cancer immunotherapy prediction tests for healthcare professionals, laboratories, and individual consumers.

LiquidCell Dx

This company develops blood-based liquid biopsy tests for tumor microenvironment profiling to help pharmaceutical companies and clinical partners predict cancer therapy responses.

GeneCentric

This company develops gene expression-based liquid biopsy platforms and biomarkers to help pharmaceutical and diagnostic firms identify cancer treatment responders.

Foresight Diagnostics

This company develops liquid biopsy tests to detect minimal residual disease in cancer patients for biopharmaceutical companies and healthcare providers.

Strata Oncology

This company provides genomic profiling tests and data software to help healthcare systems and pharmaceutical firms match cancer patients with precision therapies.

Lucid Genomics

This company develops an artificial intelligence platform for long-read genomic data interpretation to assist clinical laboratories and pharmaceutical researchers with diagnostics.

Arima Genomics

This company develops 3D genomic sequencing kits and clinical diagnostic tests for researchers and pharmaceutical companies to identify cancer-driving genetic alterations.